Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Prognostic Significance of PWWP2B Expression in AML Patients Treated with Intensive Chemotherapy

Cheng-Yeh Chen, Xavier Cheng-Hong Tsai, Kuojui Sun, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Bor-Sheng Ko, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hwei-Fang Tien, Hsin-An Hou

Blood (2024) 144 (Supplement 1): 6149.

https://doi.org/10.1182/blood-2024-209914

Published: 2024

Journal Articles

Clinical Features and Prognostic Implications of BCMA , BAFF , and APRIL Expression in Acute Myeloid Leukemia

Yun-Tzu Lin, Xavier Cheng-Hong Tsai, Kuojui Sun, Min Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien

Blood (2024) 144 (Supplement 1): 6159.

https://doi.org/10.1182/blood-2024-211928

Published: 2024

Journal Articles

Golcadomide Extends Survival of Lymphoma GEMM Mice in Combination with a CD20xCD3 T-Cell Bispecific through Increased T-Cell Activation and Infiltration

Yumi Nakayama, Ajit Dhadve, Wen Liu, Lei Wu, Neelam Kumari, Amrutha Y, Riddhita Deb, Vijayaragavan Appanasamy, Laura Armstrong, Asier Antoranz, Mark Kaplan, Sambuddho Mukherjee, Anita K. Gandhi, Patrick R. Hagner

Blood (2024) 144 (Supplement 1): 1617.

https://doi.org/10.1182/blood-2024-200370

Published: 2024

Journal Articles

Osteocytes regulate neutrophil development through IL-19: a potent cytokine for neutropenia treatment

Min Xiao, Wuju Zhang, Wen Liu, Linlin Mao, Jincheng Yang, Le Hu, Sheng Zhang, Yaling Zheng, Anling Liu, Qiancheng Song, Yuhua Li, Guozhi Xiao, Zhipeng Zou, Xiaochun Bai

Blood (2021) 137 (25): 3533–3547.

https://doi.org/10.1182/blood.2020007731

Published: 2021

Includes: Supplemental data

Journal Articles

Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy

Cheng-Hong Tsai, MD MSc, Jih-Luh Tang, MD, PhD, Feng-Ming Tien, MD, M.Sc, Yuan-Yeh Kuo, PhD, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Yen-Ling Peng, M.Sc., Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, PhD, Wen-Chien Chou, MD, PhD, Chien-Yu Chen, PhD, Hsin-An Hou, Hwei-Fang Tien, MD, PhD

Blood (2019) 134 (Supplement_1): 2698.

https://doi.org/10.1182/blood-2019-126870

Published: 2019

Journal Articles

The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia

Chao-Hung Wei, MD, Cheng-Hong Tsai, MD, M.Sc., Jih-Luh Tang, MD, PhD, Yuan-Yeh Kuo, PhD, Feng-Ming Tien, MD, M.Sc, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, MD, Liang-In Lin, PhD, Wen-Chien Chou, MD, PhD, Chien-Yu Chen, PhD, Hsin-An Hou, Hwei-Fang Tien, MD, PhD

Blood (2019) 134 (Supplement_1): 2705.

https://doi.org/10.1182/blood-2019-124657

Published: 2019

Journal Articles

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

Richard Kulmacz, PhD, Hamidreza Farzaneh, MS, Kathryn L McElhinney, BS, Jose M. Rodriguez, BS, Nicole C. Thomason, BS, Ehsan Irajizad, BE, Vladimir Berka, PhD, Wen Liu, PhD, Modupe Idowu, MD, Harinder S. Juneja, MD

Blood (2018) 132 (Supplement 1): 3654.

https://doi.org/10.1182/blood-2018-99-119885

Published: 2018

Journal Articles

The Implications of Endoplasmic Reticulum Stress Response in the Prognosis and Pathogenesis of Myelodysplastic Syndrome

Ming-En Lin, MD, Wen-Chien Chou, MD, PhD, Yu-Chiao Chiu, PhD, Mei-Hsuan Tseng, M.Sc., Ming-Chih Liu, Chia-Wen Liu, Jih-Luh Tang, MD,PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Chien-Yuan Chen, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Hsin-An Hou, MD, PhD, Shang-Ju Wu, MD, PhD, Chien-Ting Lin, MD, Woei Tsai, MD, PhD, Yidong Chen, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 4249.

https://doi.org/10.1182/blood.V130.Suppl_1.4249.4249

Published: 2017

Journal Articles

Histone Deacetylation Inhibitor Sensitizes T-ALLs to Topoisomerase II Inhibitor By Attenuating G2 Cell Cycle Arrest and Blocking Nuclear Entry of Ctip during DNA Repair

Jin-Hwang Liu, MD PhD, Yu-Hern Lin, MS, Hon-Wen Liu, PhD, Jyh-Pyng Gau, MD

Blood (2015) 126 (23): 4862.

https://doi.org/10.1182/blood.V126.23.4862.4862

Published: 2015

Journal Articles

Blood Antioxidant Defenses and Sickle Cell Disease: Analyzing Cytochrome b Reductase 1 Protein Levels and Structure in Erythrocyte Membranes

Richard J Kulmacz, PhD, Wen Liu, PhD, Vladimir Berka, PhD, Mohammad H. Rahbar, PhD, Modupe Idowu, MD, Alex George, MD, PhD, Harinder S. Juneja, MD

Blood (2015) 126 (23): 2170.

https://doi.org/10.1182/blood.V126.23.2170.2170

Published: 2015

Journal Articles

DNMT3A mutations in De Novo Myelodysplastic Syndrome: Distinct Clinico-Biological Features and Prognostic Relevance

Blood (2012) 120 (21): 3799.

https://doi.org/10.1182/blood.V120.21.3799.3799

Published: 2012

Journal Articles

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

Shang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, Li-Yu Li, Mei-Hsuan Tseng, Chi-Fei Huang, Fen-Yu Lee, Ming-Chih Liu, Chia-Wen Liu, Chien-Ting Lin, Chien-Yuan Chen, Wen-Chien Chou, Ming Yao, Shang-Yi Huang, Bor-Sheng Ko, Jih-Luh Tang, Woei Tsay, Hwei-Fang Tien

Blood (2012) 120 (15): 3106–3111.

https://doi.org/10.1182/blood-2012-02-412296

Published: 2012

Includes: Supplemental data

Journal Articles

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications

Blood (2012) 119 (2): 559–568.

https://doi.org/10.1182/blood-2011-07-369934

Published: 2012

Includes: Supplemental data

Journal Articles

DNMT3A Mutations in Acute Myeloid Leukemia-Stability During Disease Evolution and the Clinical Implication

Blood (2011) 118 (21): 409.

https://doi.org/10.1182/blood.V118.21.409.409

Published: 2011

Journal Articles

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

Blood (2011) 118 (14): 3803–3810.

https://doi.org/10.1182/blood-2011-02-339747

Published: 2011

Includes: Supplemental data

Journal Articles

Kit-Shp2- Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool

Helen He Zhu, Kaihong Ji, Nazilla Alderson, Zhao He, Shuangwei Li, Wen Liu, Dong-Er Zhang, Linheng Li, Gen-Sheng Feng

Blood (2011) 117 (20): 5350–5361.

https://doi.org/10.1182/blood-2011-01-333476

Published: 2011

Includes: Supplemental data

Journal Articles

Indirubin-3'-Monoxime Induces Apoptosis and Autophagy In Acute Lymphoblastic Leukemia Cells and Chronic Myelogenous Leukemia Cells, Exhibits Limited Cytotoxicity In CD34 + Hematopoietic Stem Cells, Lymphocytes and Granulocytes

Ming-Yang Lee, Yi-Wen Liu, Ming-Ho Chen, Jing-Jing Chuang

Blood (2010) 116 (21): 3984.

https://doi.org/10.1182/blood.V116.21.3984.3984

Published: 2010

Journal Articles

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 ( ASXL1 ) mutations

Blood (2010) 116 (20): 4086–4094.

https://doi.org/10.1182/blood-2010-05-283291

Published: 2010

Includes: Supplemental data

Journal Articles

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation

Wen-Chien Chou, Hsin-An Hou, Chien-Yuan Chen, Jih-Luh Tang, Ming Yao, Woei Tsay, Bor-Shen Ko, Shang-Ju Wu, Shang-Yi Huang, Szu-Chun Hsu, Yao-Chang Chen, Yen-Ning Huang, Yi-Chang Chang, Fen-Yu Lee, Ming-Chi Liu, Chia-Wen Liu, Mei-Hsuan Tseng, Chi-Fei Huang, Hwei-Fang Tien

Blood (2010) 115 (14): 2749–2754.

https://doi.org/10.1182/blood-2009-11-253070

Published: 2010

Includes: Supplemental data

Journal Articles

Indirubin-3-Monoxime Induces Apoptosis and Autophagy in Human Lymphocytic Leukemia Cells and Human Chronic Myelogenous Leukemia Cells.

Ming-Yang Lee, MD, Jing-Jing Chuang, Ph.D., Yi-Wen Liu, Ph.D.

Blood (2009) 114 (22): 4106.

https://doi.org/10.1182/blood.V114.22.4106.4106

Published: 2009

NARROW

Clinical Characteristics and Prognostic Significance of PWWP2B Expression in AML Patients Treated with Intensive Chemotherapy

Clinical Features and Prognostic Implications of BCMA , BAFF , and APRIL Expression in Acute Myeloid Leukemia

Golcadomide Extends Survival of Lymphoma GEMM Mice in Combination with a CD20xCD3 T-Cell Bispecific through Increased T-Cell Activation and Infiltration

Osteocytes regulate neutrophil development through IL-19: a potent cytokine for neutropenia treatment

Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy

The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

The Implications of Endoplasmic Reticulum Stress Response in the Prognosis and Pathogenesis of Myelodysplastic Syndrome

Histone Deacetylation Inhibitor Sensitizes T-ALLs to Topoisomerase II Inhibitor By Attenuating G2 Cell Cycle Arrest and Blocking Nuclear Entry of Ctip during DNA Repair

Blood Antioxidant Defenses and Sickle Cell Disease: Analyzing Cytochrome b Reductase 1 Protein Levels and Structure in Erythrocyte Membranes

DNMT3A mutations in De Novo Myelodysplastic Syndrome: Distinct Clinico-Biological Features and Prognostic Relevance

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications

DNMT3A Mutations in Acute Myeloid Leukemia-Stability During Disease Evolution and the Clinical Implication

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

Kit-Shp2- Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool

Indirubin-3'-Monoxime Induces Apoptosis and Autophagy In Acute Lymphoblastic Leukemia Cells and Chronic Myelogenous Leukemia Cells, Exhibits Limited Cytotoxicity In CD34 + Hematopoietic Stem Cells, Lymphocytes and Granulocytes

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 ( ASXL1 ) mutations

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation

Indirubin-3-Monoxime Induces Apoptosis and Autophagy in Human Lymphocytic Leukemia Cells and Human Chronic Myelogenous Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only